Image For Activity Cover
Core Concepts in EP 2023 w/ Board Prep and Self Assessment
Description
Core Concepts in EP and Board Prep has evolved from the Society's highly regarded Board Review Course and is designed to serve as an indispensible tool for preparing for the CCEP Exam. It also ensures a fundamentally sound EP knowledge base.

This course features didactic lectures and case-based workshops presented by expert faculty and course directors for in-depth coverage of the essential EP curriculum. It is bundled with a 100-question, multiple choice Self-Assessment Exam available immediately upon purchase.



Course Highlights

Over 20 recorded didactic lectures with nine case-based workshops delivered by leading experts covering:
  • Basic cardiac and intracardiac electrophysiology
  • Pharmacology of antiarrhythmic drugs
  • Noninvasive testing for arrhythmias
  • Atrial and other supraventricular tachycardias
  • Catheter ablation
  • Implantable cardioverter defibrillators
  • Cardiac pacing
  • Intracardiac ultrasound in EP
  • Transseptal catheterization techniques
  • Pericardial access for epicardial mapping and ablation
  • Complications of EP procedures - avoidance and management


Program Details

Welcome and Overview of Course


Board Prep

  • Strategies for Success: Preparing for the Boards
  • Testable Concepts

Module I: Basic Science and Fundamentals of Electrophysiology

  • Basic Electrophysiology Principles for the Clinician
  • Inherited Ion Channelopathies
  • Sinoatrial and Atrioventricular Nodes and His-Purkinje System: Anatomy, Evaluation, Autonomics and Therapy
  • Retrograde Conductions
  • Workshop #1: Electrocardiographic/Electrophysiologic Correlations
    • Physiology and Conduction
    • Basic Science and Channelopathies
    • Basic Science

Module II: Invasive Diagnosis and Treatment

  • Use of Overdrive Pacing/Entrainment in Supraventricular Tachycardia
  • Principles of Entrainment: Ventricular Tachycardia
  • Techniques of Differentiating SVT Mechanisms: Part I
  • Techniques of Differentiating SVT Mechanisms: Part II
  • Workshop #2: Entrainment and SVT Maneuvers
    • SVT Maneuvers Cases
    • Entrainment Cases  – VT
    • Entrainment Cases – SVT
  • Catheter Ablation of Atrial Tachycardia and Typical Atrial Flutter
  • Physiology, Mapping and Catheter Ablation of Accessory Pathways
  • Workshop #3: SVT Mechanisms/Maneuvers
  • Physiology of Catheter Ablation of AV Nodal Reentrant Tachycardia
  • Special Workshop: 12 Lead ECG for PVC and VT Localization

Module III: Invasive Diagnosis and Treatment

  • Ventricular Tachycardia: Ischemic and Nonischemic Cardiomyopathy and other Unique VT Syndromes
  • Workshop #4: SVT and VT Invasive/Noninvasive Correlation
  • Wide Complex Tachycardias: Idiopathic VTs, Bundle Branch Reentry, Antidromic Tachycardias – Mechanisms, ECG Manifestations, Invasive Assessment and Ablation
  • Workshop #5: Invasive/Noninvasive Correlation

Module IV: Noninvasive Diagnosis and Treatment

  • Antiarrhythmic Drugs: Part I
  • Antiarrhythmic Drugs: Part II - Case Scenarios
  • Workshop #6: Electrocardiographic/Electrophysiological Correlations
  • Mechanisms, Pharmacologic, and Non-Pharmacologic Treatment of Atrial Fibrillation
  • Biophysics of Catheter Ablation
  • Workshop #7: Electrocardiographic/Electrophysiological Correlations, Atrial Fibrillation, Clinical Scenarios and Syndromes

Module V: Clinical Scenarios/Device Management

  • Implantable Devices: Evaluation, Management and Troubleshooting
  • Workshop #8: Device Cases
  • Workshop #9: Arrhythmia Case Studies/Putting It All Together for the Board
  • Testable Concepts

Special Technology Sessions

  • Transseptal Catheterization
  • Complications of Electrophysiologic Studies – Avoidance and Treatment
  • Use of Intracardiac Ultrasound in Electrophysiology Procedures
  • Pericardial Access for Epicardial Mapping and Ablation
  • Cardiac Conduction System Pacing – Theory and Practice
  • Electroanatomical Mapping – Principles and Pitfalls
Learning Objectives
  1. Describe the current guidelines related to evaluation and management of patients with cardiac rhythm disturbances
  2. Describe the role of electrophysiologic testing in managing patients with brady arrhythmias and tachyarrhythmias
  3. Identify the advantages and limitations of diagnostic electrophysiologic methods
  4. Identify the role of pharmacologic and non-pharmacologic therapies for the treatment of arrhythmias
  5. Recognize the basic electrophysiology and genetics of inherited conditions associated with cardiac arrhythmias
  6. Recognize clinical, electrocardiographic, and electrophysiologic characteristics of specific cardiac arrhythmia syndromes
  7. Interpret complex electrophysiologic and electrocardiographic tracings
  8. Interpret stored electrograms from pacemakers and ICDs
  9. Understand the role, utility and limitations of imaging (fluoroscopy, intracardiac echocardiography, electroanatomic mapping) in electrophysiologic procedures
  10. Understand different methods of safely accessing left atrium with transseptal techniques, and pericardial space for electrophysiologic procedures
  11. Describe potential complications of electrophysiologic procedures, how to avoid them when possible and remedy them when they occur
Target Audience
  • EP Fellows
  • MDs taking the ABIM CCEP Board Certification Exam
  • MDs taking the ABIM CCEP Recertification Exam
Faculty
John M. Miller, MD, FHRS
Indiana University School of Medicine I Director, Clinical Cardiac EP

Gregory F. Michaud, MD, FHRS
Vanderbilt University Medical School Chief, Arrhythmia Science I Professor of Medicine

Kenneth A. Ellenbogen, MD, FHRS
Virginia Commonwealth University Medical Center I Cardiology Chair

Samuel J. Asirvatham, MD, FHRS
Mayo Clinic I Professor of Medicine and Pediatrics

David J. Callans, MD, FHRS, CCDS
Hospital of the University of Pennsylvania

Edward P. Gerstenfeld, MD, FHRS
University of California, San Francisco I Professor

Mathew D. Hutchinson, MD, FHRS
Sarver Heart Center, University of Arizona I Attending Physician

Barry London, MD, PhD
University of Iowa I Professor

Francis E. Marchlinski, MD, FHRS
Hospital of the University of Pennsylvania, Cardiac Electrophysiology I Professor of Medicine

William M. Miles, MD, FHRS
University of Florida I Professor of Medicine

Jeanne E. Poole, MD, FHRS
University of Washington School of Medicine I Faculty

William G. Stevenson, MD, FHRS
Vanderbilt University Medical Center I Professor of Medicine

Gordon F. Tomaselli, MD, FHRS
Johns Hopkins University School of Medicine I Professor of Medicine

Roderick Tung, MD, FHRS
University of Chicago I Associate Professor of Medicine

Pugazhendi Vijayaraman, MD, FHRS
Geisinger Heart Institute 
Disclosure of Faculty's Commercial Relationship(s)

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

 

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.


All relevant financial relationships are reviewed and mitigated.  


Faculty Disclosures

Samuel J. Asirvtham, MD, FHRS
Honoraria/Speaking/Consulting Fee: St. Jude Medical, Medtronic, Biotronik, Boston Scientific, Biosig Technologies, MediLynx

Intellectual Property Rights: AliveCor

David J. Callans, MD, FHRS, CCDS
Honoraria/Speaking/Consulting Fee: Medtronic, Best Doctors, Biotronik, Boston Scientific, Impulse Dynamics USA, Thermedical, Biosense Webster, Inc., Baylis Medical Company, BioSig, Mediasphere Medical, Coherex, Abbott Medical
Research (Contracted Grants for PIs and Named Investigators Only): Medtronic, Boston Scientific, Biosense Webster, Inc., Biotronik, Abbott
Other Financial Relationships: Wolters Kluver (author)

Kenneth A. Ellenbogen, MD, FHRS
Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, Kestra, Inc., Hylomorph, Biotronik, MediLynx, Impulse Dynamics USA, Abbott, Biosense Webster, Inc., Milestone Pharmaceuticals
Royalty Income: Elsevier

Edward P. Gerstenfeld, MD, FHRS
Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Medtronic, Abbott, Boston Scientific

Research (Contracted Grants for PIs and Named Investigators only): Biosense Webster, Inc., Farapulse

Mathew D. Hutchinson, MD, FHRS
Honoraria/Speaking/Consulting Fee: Elsevier, Medtronic, Inc.


Barry London, MD, PhD
Nothing Relevant to Disclose.


Francis E. Marchlinski, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, Biotronik, Boston Scientific, Medtronic, Biosense Webster, Inc., Philips


Gregory F. Michaud, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, Mediasphere Medical, Boston Scientific, Biotronik, Medtronic


William M. Miles, MD, FHRS
Honoraria/Speaking/Consulting Fee: Medtronic

Fellowship Support: Medtronic, Boston Scientific, St. Jude Medical, Biosense Webster, Inc., Biotronik

John M. Miller, MD, FHRS
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster, Inc., Biotronik, BioSig, Medtronic, Abbott, Ablacon, Inc. 

Royalty Income: Elsevier
Fellowship Support: Medtronic, Boston Scientific, Biosense Webster, Inc.

Jeanne E. Poole, MD, FHRS
Honoraria/Speaking/Consulting Fee: EBR Systems

Research (Contracted Grants for PIs and Named Investigators only): Kestra, Inc., AtriCure, Inc., Biotronik
Royalty Income: Elsevier

William G. Stevenson, MD, FHRS
Stocks - Publicly Traded: Apple Inc.

Gordon F. Tomaselli, MD, FHRS
Ownership/Partnership/Principal: Domicell, LLC

Roderick Tung, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, AtriCure, Inc., Biotronik, Medtronic


Pugazhendi Vijayaraman, MD, FHRS
Honoraria/Speaking/Consulting Fee: Abbott, Medtronic, Biotronik, Boston Scientific

Research (Contracted Grants for PIs and Named Investigators only): Medtronic
Fellowship Support: Medtronic


The content reviewers have the following disclosures. All relevant financial relationship disclosures have been mitigated.

David Ho, BS, MD, MS
Nothing relevant to disclose.


Venkatakrishna Tholakanahalli, MD
Kobara Medical Inc, Relationship: Intellectual Property Rights, Role: Consulting; St. Jude Medical, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Research Studies , Coordinator salary support; Cardialen, Inc., Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Research coordinator salary and fellow education; Imricor, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Consulting, Comments: Towards Education for trainees

Komandoor Srivathsan, MD
Abbott Medical, Relationship: Honoraria/Speaking/Consulting Fee, Role: Speaking and Teaching


M. Rizwan Afzal, MD
Nothing relevant to disclose.


Rachita Navara, MD
SafeBeat RX Inc. (Research Organization), Relationship: Ownership/Partnership/Principal, Role: Ownership


Thomas McGarry, MD, PhD
Nothing relevant to disclose.

Jorge Romero, MD
Biosense Webster, Inc., Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research, Comments: Investigator-initiated research study (PLEA AF trial) NCT#04216667; Organization: Sanofi, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Organization: Boston Scientific, Relationship: Honoraria/Speaking/Consulting Fee, Role: Speaking and Teaching; Organization: AtriCure, Inc., Relationship: Honoraria/Speaking/Consulting Fee, Role: Board Membership


Ayman Hussein, MD
Boston Scientific, Relationship: Research (Contracted Grants for PIs and Named Investigators only), Role: Research


Leon Ptaszek, MD, PhD
Bristol-Myers Squibb, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Pfizer, Inc., Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; World Care Clinical Consultants, Relationship: Honoraria/Speaking/Consulting Fee, Consulting; Moderna Therapeutics, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting, Abbott, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Neutrace, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Aquaheart, Relationship: Honoraria/Speaking/Consulting Fee, Role: Consulting; Neutrace: Research (Contracted Grants for PIs and Named Investigators only), Role: Research



The following Heart Rhythm Society Staff have nothing relevant to disclose:

Gary Bird
Jordan Glenn
Sarah Sailor, MFA

Contact Information
ACE Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your ACE certificate, please contact CME@HRSonline.org 
Summary
Availability: Expires on May 19, 2026
Cost: Member: $1,425.00
Non-Member: $2,100.00
Credit Offered:
46 ACE Credits
46 COP Credits
46 ABIM-MOC Points
46 ABP-MOC Points
Contains: 3 Courses
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By